Skip to content

Unicirc vs Open Surgical Circumcision

Adult Male Circumcision With Unicirc Under Topical Anesthetic vs Open Surgical Circumcision: a Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02443792
Acronym
Unicirc004
Enrollment
75
Registered
2015-05-14
Start date
2015-04-30
Completion date
2015-09-30
Last updated
2018-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circumcision, Male

Brief summary

RCT of Unicirc under topical anesthetic w/ cyanoacrylate wound sealing vs. open surgical circumcision under local anesthetic with suturing.

Interventions

PROCEDUREOpen Surgical

As above

Sponsors

Simunye Primary Health Care
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male * Uncircumcised * With normal penile anatomy

Exclusion criteria

* Concurrent illness * History of bleeding disorder * Past reaction to local anesthetic * Infection * Penile abnormality which could complicate circumcision

Design outcomes

Primary

MeasureTime frameDescription
Time Elapsed From First Clamp (Surgical) or Start of Insertion of Bell (Unicirc) to Beginning of Wound DressingUp to 30 minutesTime elapsed from first clamp (surgical) or start of insertion of bell (Unicirc) to beginning of wound dressing

Secondary

MeasureTime frameDescription
Surgical Pain 0=no Pain; 10=Worst Pain EverUp to 30 minutesSelf-described pain severity during procedure (scale 1 to 10). 0=no pain, 5=moderate pain, 10=worst pain ever
Completely Healed at 4 WeeksAt the 4-week followup visitNumber of participants who were completely healed at 4 weeks
Wound DehiscenceUp to 4 weeksProportion experiencing wound dehiscence (\< 2 cm vs \> 2 cm)
InfectionUp to 4 weeksProportion experiencing post-op infection, determined clinically (treated with antibiotics)

Countries

South Africa

Participant flow

Participants by arm

ArmCount
Unicirc With Tissue Adhesive
Unicirc under topical anesthetic w/ cyanoacrylate wound sealing Unicirc with tissue adhesive: As above
50
Open Surgical
Open surgical circumcision under local anesthetic with suturing Open Surgical: As above
25
Total75

Baseline characteristics

CharacteristicUnicirc With Tissue AdhesiveOpen SurgicalTotal
Age, Customized
Age 18-25
3 participants2 participants5 participants
Age, Customized
Age 26-35
19 participants12 participants31 participants
Age, Customized
Age 36+
28 participants11 participants39 participants
Region of Enrollment
South Africa
50 participants25 participants75 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
50 Participants25 Participants75 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
3 / 500 / 25
serious
Total, serious adverse events
0 / 500 / 25

Outcome results

Primary

Time Elapsed From First Clamp (Surgical) or Start of Insertion of Bell (Unicirc) to Beginning of Wound Dressing

Time elapsed from first clamp (surgical) or start of insertion of bell (Unicirc) to beginning of wound dressing

Time frame: Up to 30 minutes

ArmMeasureValue (MEDIAN)
Unicirc With Tissue AdhesiveTime Elapsed From First Clamp (Surgical) or Start of Insertion of Bell (Unicirc) to Beginning of Wound Dressing12 Minutes
Open SurgicalTime Elapsed From First Clamp (Surgical) or Start of Insertion of Bell (Unicirc) to Beginning of Wound Dressing25 Minutes
Secondary

Completely Healed at 4 Weeks

Number of participants who were completely healed at 4 weeks

Time frame: At the 4-week followup visit

ArmMeasureValue (NUMBER)
Unicirc With Tissue AdhesiveCompletely Healed at 4 Weeks39 participants
Open SurgicalCompletely Healed at 4 Weeks16 participants
Secondary

Infection

Proportion experiencing post-op infection, determined clinically (treated with antibiotics)

Time frame: Up to 4 weeks

ArmMeasureValue (NUMBER)
Unicirc With Tissue AdhesiveInfection0 participants
Open SurgicalInfection0 participants
Secondary

Surgical Pain 0=no Pain; 10=Worst Pain Ever

Self-described pain severity during procedure (scale 1 to 10). 0=no pain, 5=moderate pain, 10=worst pain ever

Time frame: Up to 30 minutes

ArmMeasureValue (MEAN)Dispersion
Unicirc With Tissue AdhesiveSurgical Pain 0=no Pain; 10=Worst Pain Ever1.7 units on a scaleStandard Deviation 1.3
Open SurgicalSurgical Pain 0=no Pain; 10=Worst Pain Ever1.9 units on a scaleStandard Deviation 2.4
Secondary

Wound Dehiscence

Proportion experiencing wound dehiscence (\< 2 cm vs \> 2 cm)

Time frame: Up to 4 weeks

ArmMeasureGroupValue (NUMBER)
Unicirc With Tissue AdhesiveWound DehiscenceDehiscence < 2 cm longitudinally14 participants
Unicirc With Tissue AdhesiveWound DehiscenceDehiscence > 2 cm longitudinally0 participants
Open SurgicalWound DehiscenceDehiscence > 2 cm longitudinally0 participants
Open SurgicalWound DehiscenceDehiscence < 2 cm longitudinally4 participants

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026